Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma

Despite recent advances in diagnosis and treatment, glioblastoma (GBM) represents the most common and aggressive brain tumor in the adult population, urging identification of new rational therapeutic targets. Galectins, a family of glycan-binding proteins, are highly expressed in the tumor microenvi...

Descripción completa

Detalles Bibliográficos
Autores principales: Videla-Richardson, Guillermo A., Morris-Hanon, Olivia, Torres, Nicolás I., Esquivel, Myrian I., Vera, Mariana B., Ripari, Luisina B., Croci, Diego O., Sevlever, Gustavo E., Rabinovich, Gabriel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745137/
https://www.ncbi.nlm.nih.gov/pubmed/35008740
http://dx.doi.org/10.3390/ijms23010316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745137/
https://www.ncbi.nlm.nih.gov/pubmed/35008740
http://dx.doi.org/10.3390/ijms23010316

Ejemplares similares